0.6705
price down icon50.00%   -0.7095
 
loading

Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스

pulisher
01:21 AM

Medicus Pharma Ltd Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance And 40% Histological Clearance (CR) At Day 57 In 200µg Cohort - marketscreener.com

01:21 AM
pulisher
12:00 PM

Medicus Pharma reports positive phase 2 results for microneedle skin cancer treatment - Proactive financial news

12:00 PM
pulisher
09:19 AM

MDCX Navigates Uncertain Waters Amid Recent Earnings and Market Trends - timothysykes.com

09:19 AM
pulisher
09:13 AM

Medicus Pharma Stock Swings After Skin Cancer Treatment Results - Benzinga

09:13 AM
pulisher
08:35 AM

Medicus Pharma reports positive Phase 2 results for microneedle treatment for basal cell carcinoma - Yahoo Finance

08:35 AM
pulisher
08:26 AM

Medicus Pharma Posts Strong Phase 2 Data for Microneedle Basal Cell Carcinoma Therapy - TipRanks

08:26 AM
pulisher
07:39 AM

Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort - Bitget

07:39 AM
pulisher
01:32 AM

Medicus Pharma on Bloomberg World - Bluffton Today

01:32 AM
pulisher
Mar 03, 2026

New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - ACCESS Newswire

Mar 03, 2026
pulisher
Mar 03, 2026

Medicus Pharma Showcases SkinJect and Teverelix Strategy at Roth Conference - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

Medicus Pharma to present at Roth Conference - Proactive financial news

Mar 03, 2026
pulisher
Mar 03, 2026

Medicus Pharma To Participate in the 38th Annual Roth Conference - The Manila Times

Mar 03, 2026
pulisher
Mar 03, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Mar 03, 2026
pulisher
Mar 01, 2026

Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform - Treasure Coast News

Mar 01, 2026
pulisher
Feb 26, 2026

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - The Town Talk

Feb 26, 2026
pulisher
Feb 25, 2026

MDCX PE Ratio & Valuation, Is MDCX Overvalued - Intellectia AI

Feb 25, 2026
pulisher
Feb 25, 2026

Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - Montgomery Advertiser

Feb 25, 2026
pulisher
Feb 24, 2026

MDCX Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 24, 2026
pulisher
Feb 23, 2026

MDCX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 23, 2026
pulisher
Feb 22, 2026

Reliant AI – Weekly Recap - TipRanks

Feb 22, 2026
pulisher
Feb 21, 2026

Can Medicus Pharma Ltd. sustain its profitabilityRate Hike & High Win Rate Trade Alerts - mfd.ru

Feb 21, 2026
pulisher
Feb 21, 2026

Aug Technicals: Why is Medicus Pharma Ltd stock going downQuarterly Market Review & AI Forecasted Stock Moves - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 21, 2026

Market Outlook: How is Redwood Trust Inc managing supply chain issuesQuarterly Trade Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 19, 2026

Medicus Pharma receives FDA clearance to begin Phase 2b Teverelix study - MSN

Feb 19, 2026
pulisher
Feb 19, 2026

Reliant AI Partnership Targets Faster, More Efficient Clinical Trials - TipRanks

Feb 19, 2026
pulisher
Feb 19, 2026

Reliant AI Partnership Targets Faster, More Efficient Clinical Trials With Medicus Pharma - TipRanks

Feb 19, 2026
pulisher
Feb 16, 2026

Medicus Pharma Receives FDA Clearance to Begin Phase 2b Teverelix Study - MyChesCo

Feb 16, 2026
pulisher
Feb 15, 2026

Is Medicus Pharma Ltd. Equity Warrant vulnerable to short sellersShare Buyback & Stepwise Trade Execution Plans - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Does Medicus Pharma Ltd. Equity Warrant have declining or rising EPS2025 Support & Resistance & Fast Entry High Yield Stock Tips - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Medicus Pharma’s Teverelix Phase 2b trial cleared by FDAICYMI - Proactive financial news

Feb 14, 2026
pulisher
Feb 14, 2026

Can Medicus Pharma Ltd. Equity Warrant ride the EV waveWeekly Market Outlook & Short-Term High Return Ideas - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Aug Reactions: Is Medicus Pharma Ltd Equity Warrant subject to activist investor interestEarnings Performance Report & High Win Rate Trade Tips - baoquankhu1.vn

Feb 14, 2026
pulisher
Feb 14, 2026

Is Medicus Pharma Ltd. Equity Warrant a speculative investmentGold Moves & Low Volatility Stock Suggestions - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Will Medicus Pharma Ltd. Equity Warrant benefit from rising consumer demand2025 Top Decliners & Comprehensive Market Scan Insights - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Why Medicus Pharma Ltd. stock attracts high net worth investorsDollar Strength & High Win Rate Trade Alerts - mfd.ru

Feb 13, 2026
pulisher
Feb 13, 2026

Aug Decliners: Is Medicus Pharma Ltd Equity Warrant likely to announce a buybackMarket Trend Review & Short-Term High Return Strategies - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 13, 2026

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Asbury Park Press

Feb 13, 2026
drug_manufacturers_general PFE
$26.52
price down icon 0.30%
drug_manufacturers_general NVO
$38.73
price up icon 0.68%
$143.94
price down icon 2.72%
$361.86
price down icon 4.36%
drug_manufacturers_general MRK
$115.57
price down icon 3.76%
drug_manufacturers_general AZN
$195.53
price down icon 2.92%
자본화:     |  볼륨(24시간):